Published in J Exp Med on April 01, 1992
Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients. Clin J Am Soc Nephrol (2008) 2.08
Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice. J Clin Invest (2008) 1.94
Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals. Clin Exp Immunol (2008) 1.89
Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice. Proc Natl Acad Sci U S A (2006) 1.87
Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome. EMBO J (2006) 1.72
Dense deposit disease associated with monoclonal gammopathy of undetermined significance. Am J Kidney Dis (2010) 1.57
Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency. J Clin Invest (1995) 1.57
Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site. Am J Pathol (2005) 1.40
Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association? Clin J Am Soc Nephrol (2011) 1.31
Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice. Kidney Int (2010) 1.25
C3 glomerulonephritis associated with monoclonal gammopathy: a case series. Am J Kidney Dis (2013) 1.24
Recent insights into C3 glomerulopathy. Nephrol Dial Transplant (2013) 1.21
Factor B of the alternative complement pathway regulates development of airway hyperresponsiveness and inflammation. Proc Natl Acad Sci U S A (2006) 1.14
Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phase. Mol Immunol (2009) 1.09
MPGN II--genetically determined by defective complement regulation? Pediatr Nephrol (2006) 1.02
Factor h: a complement regulator in health and disease, and a mediator of cellular interactions. Biomolecules (2012) 0.99
Dense deposit disease and C3 glomerulopathy. Semin Nephrol (2013) 0.98
Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach. J Am Soc Nephrol (2015) 0.96
Clinical findings, pathology, and outcomes of C3GN after kidney transplantation. J Am Soc Nephrol (2013) 0.95
The molecular basis for hereditary porcine membranoproliferative glomerulonephritis type II: point mutations in the factor H coding sequence block protein secretion. Am J Pathol (2002) 0.95
Molecules Great and Small: The Complement System. Clin J Am Soc Nephrol (2015) 0.91
Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis. Clin Exp Immunol (2007) 0.85
Paraprotein-Related Kidney Disease: Glomerular Diseases Associated with Paraproteinemias. Clin J Am Soc Nephrol (2016) 0.81
Paraprotein-Related Kidney Disease: Kidney Injury from Paraproteins-What Determines the Site of Injury? Clin J Am Soc Nephrol (2016) 0.80
Recovery of renal function succeeding stem cell transplant: a case of C3 Glomerulonephiritis secondary to monoclonal gammopathy. Clin Kidney J (2013) 0.78
Novel targets for immunotherapy in glomerulonephritis. Biologics (2008) 0.77
Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GN. World J Nephrol (2016) 0.76
Anti-complement-factor H-associated glomerulopathies. Nat Rev Nephrol (2016) 0.76
Complement Factor H Binds to Human Serum Apolipoprotein E and Mediates Complement Regulation on High Density Lipoprotein Particles. J Biol Chem (2015) 0.75
Overview of C3 Glomerulopathy. Front Pediatr (2016) 0.75
C3 glomerulopathy associated to multiple myeloma successfully treated by autologous stem cell transplant. Indian J Nephrol (2017) 0.75
Activation of complement system in kidney after ketoprofen-induced kidney injury in sheep. Acta Vet Scand (2015) 0.75
C3 glomerulopathy in adults: a distinct patient subset showing frequent association with monoclonal gammopathy and poor renal outcome. Clin Kidney J (2016) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science (1954) 21.20
Control of the amplification convertase of complement by the plasma protein beta1H. Proc Natl Acad Sci U S A (1976) 6.65
Large scale isolation of functionally active components of the human complement system. J Biol Chem (1981) 5.26
Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms. Proc Natl Acad Sci U S A (1977) 5.23
Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells. Proc Natl Acad Sci U S A (1978) 4.94
Serum C'3 lytic system in patients with glomerulonephritis. Science (1969) 4.44
Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc Natl Acad Sci U S A (1990) 2.79
C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase. J Immunol (1976) 2.64
Complement studies in membrano-proliferative glomerulonephritis. Clin Exp Immunol (1972) 2.60
Glomerular deposition of properdin in Henoch-Schönlein syndrome and idiopathic focal nephritis. Br Med J (1973) 2.07
The alternative pathway of complement. Springer Semin Immunopathol (1984) 2.01
IgA nephropathy. Am J Pathol (1974) 1.94
Studies of serum complement in the hypocomplementaemic nephritides. Clin Exp Immunol (1974) 1.67
A serum factor in chronic hypocomplementemic hephritis distinct from immunoglobulins and activating the alternate pathway of complement. J Exp Med (1974) 1.63
H deficiency in two brothers with atypical dense intramembranous deposit disease. Kidney Int (1986) 1.55
C3 convertase of human complement: enhanced formation and stability of the enzyme generated with nickel instead of magnesium. J Immunol (1982) 1.48
The immunogloblin nature of nephritic factor (NeF). Clin Exp Immunol (1978) 1.47
Heterogeneity of nephritic factor and its identification as an immunoglobulin. Proc Natl Acad Sci U S A (1977) 1.34
The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase. Biochem J (1986) 1.26
Heterogeneity, polypeptide chain composition and antigenic reactivity of C3 nephritic factor. J Immunol (1978) 1.21
Common binding region of complement factors B, H and CR1 on C3b revealed by monoclonal anti-C3d. Complement Inflamm (1989) 1.18
A fluorimetric assay for native C3. The hemolytically active form of the third component of human complement. J Immunol Methods (1987) 1.15
A mechanism of activation of the alternative complement pathway by the classical pathway: protection of C3b from inactivation by covalent attachment to C4b. Eur J Immunol (1990) 0.97
Complement activation by circulating serum factors in human glomerulonephritis. Clin Exp Immunol (1985) 0.93
Properdin is a trimer. Mol Immunol (1982) 0.88
Similar binding properties of peptide ligands for a human immunoglobulin and its light chain dimer. Mol Immunol (1989) 0.85
Quantitation of human complement fragment C4ai in physiological fluids by competitive inhibition radioimmune assay. J Immunol Methods (1981) 0.84
Complement activation in semisolid media: insolubilization of alternative pathway convertases in agar gels with C3 nephritic factor-containing sera. J Immunol (1977) 0.84
Nonimmunoglobulin C3 activating factor in membranoproliferative glomerulonephritis. Kidney Int (1979) 0.79
Ulex europaeus I lectin as a marker for vascular endothelium in human tissues. Lab Invest (1982) 3.29
Direct detection of Mycobacterium tuberculosis complex in respiratory specimens by Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test and Roche Amplicor Mycobacterium Tuberculosis Test. J Clin Microbiol (1995) 3.28
The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J Biol Chem (2000) 3.24
Comparison of manual Amplicor PCR, Cobas Amplicor PCR, and LCx assays for detection of Chlamydia trachomatis infection in women by using urine specimens. J Clin Microbiol (1997) 2.73
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes (1999) 2.36
Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation. Infect Immun (2001) 2.03
The factor H protein family. Immunopharmacology (1999) 1.96
Detection of Chlamydia trachomatis infections in women by Amplicor PCR: comparison of diagnostic performance with urine and cervical specimens. J Clin Microbiol (1996) 1.89
Cellular origin and differentiation of renal carcinomas. A fluorescence microscopic study with kidney-specific antibodies, antiintermediate filament antibodies, and lectins. Lab Invest (1983) 1.82
Each of the three binding sites on complement factor H interacts with a distinct site on C3b. J Biol Chem (2000) 1.82
Chlamydial endometritis. J Clin Pathol (1985) 1.80
Distribution of protectin (CD59), a complement membrane attack inhibitor, in normal human tissues. Lab Invest (1991) 1.79
Partial purification of human leukocyte interferon on a large scale. Methods Enzymol (1981) 1.79
Evaluation of the Gen-Probe Chlamydia trachomatis transcription-mediated amplification assay with urine specimens from women. J Clin Microbiol (1997) 1.74
Biogenesis of podocalyxin--the major glomerular sialoglycoprotein--in the newborn rat kidney. Eur J Cell Biol (1989) 1.74
Detection of Mycobacterium tuberculosis complex in sputum specimens by the automated Roche Cobas Amplicor Mycobacterium Tuberculosis Test. J Clin Microbiol (1998) 1.68
Microbiological and histopathological findings in acute pelvic inflammatory disease. Br J Obstet Gynaecol (1987) 1.65
Factors associated with progression of IgA nephropathy are related to renal function--a model for estimating risk of progression in mild disease. Clin Nephrol (2002) 1.64
Serum CA 125 in acute pelvic inflammatory disease. Br J Obstet Gynaecol (1989) 1.62
Expression of vimentin and cytokeratin types of intermediate filament proteins in developing and adult human kidneys. Lab Invest (1984) 1.56
Long-term survival in idiopathic membranous glomerulonephritis: can the course be clinically predicted? Clin Nephrol (1994) 1.51
CSF and MRI findings in patients with acute herpes zoster. Neurology (1998) 1.49
Lectins as fluorescence microscopic markers for saccharides in the human kidney. Lab Invest (1981) 1.45
Ulex europaeus I lectin as a marker for tumors derived from endothelial cells. Am J Clin Pathol (1983) 1.44
Molecular mechanisms of target recognition in an innate immune system: interactions among factor H, C3b, and target in the alternative pathway of human complement. J Immunol (2000) 1.43
Functional properties of complement factor H-related proteins FHR-3 and FHR-4: binding to the C3d region of C3b and differential regulation by heparin. FEBS Lett (1999) 1.43
Anatomic sites of upper genital tract infection. Obstet Gynecol (1985) 1.41
Nephrin localizes at the podocyte filtration slit area and is characteristically spliced in the human kidney. Am J Pathol (1999) 1.40
Mycoplasmas and leukaemia. Res Virol (1992) 1.39
Involvement of lipid rafts in nephrin phosphorylation and organization of the glomerular slit diaphragm. Am J Pathol (2001) 1.39
Heymann nephritis induced by kidney brush border glycoproteins. Lab Invest (1980) 1.39
Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines. Acta Paediatr (1999) 1.38
Transferrin as a fetal growth factor: acquisition of responsiveness related to embryonic induction. Proc Natl Acad Sci U S A (1983) 1.35
Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years of follow-up. Am J Epidemiol (1993) 1.32
Mycoplasma hominis in nonspecific vaginitis. Sex Transm Dis (1984) 1.29
Regulation of alternative pathway complement activation by glycosaminoglycans: specificity of the polyanion binding site on factor H. Biochem Biophys Res Commun (1994) 1.26
Interaction between molecules of hantavirus nucleocapsid protein. J Gen Virol (2001) 1.26
The percentages of six immunoglobulin isotypes in human antibodies to tetanus toxoid: standardization of isotype-specific second antibodies in solid-phase assay. Eur J Immunol (1984) 1.25
A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: clinical, immunological, and epidemiological aspects. Ann Rheum Dis (2001) 1.22
Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening. J Exp Med (1986) 1.22
Prevalence and manifestations of endometritis among women with cervicitis. Am J Obstet Gynecol (1985) 1.21
Tolerance to oats in dermatitis herpetiformis. Gut (1998) 1.19
The expanding clinical spectrum of ocular lyme borreliosis. Ophthalmology (2000) 1.15
ss-cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab (2000) 1.14
Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab (1996) 1.13
Membranous glomerulonephritis in rheumatoid arthritis not related to gold or D-penicillamine therapy: a report of four cases and review of the literature. Clin Nephrol (1987) 1.13
Age-dependent variation in the serum concentration of mannan-binding protein. Acta Paediatr (1996) 1.12
Helicobacter pylori infection in Finnish children and adolescents. A serologic cross-sectional and follow-up study. Scand J Gastroenterol (1995) 1.11
Renal transplantation in amyloidosis. Acta Med Scand (1979) 1.10
IgG subclass distributions in anti-hapten and anti-polysaccharide antibodies induced by haptenated polysaccharides. Eur J Immunol (1983) 1.10
In vitro segregation of the metanephric nephron. Dev Biol (1981) 1.09
Serum thyrotrophin and circulating thyroglobulin and thyroid microsomal antibodies in a Finnish population. Acta Endocrinol (Copenh) (1979) 1.09
Smooth muscle antibodies of actin and "non-actin" specificity. Clin Immunol Immunopathol (1978) 1.09
Detection of hepatitis B surface antigen using time-resolved fluoroimmunoassay. Nature (1983) 1.07
Evidence of both anti-GBM and immune complex mediated pathogenesis in the initial phase of Goodpasture's syndrome. Clin Nephrol (1978) 1.06
Pharyngitis in adults: the presence and coexistence of viruses and bacterial organisms. Ann Intern Med (1989) 1.06
Binding of monoclonal antibodies to glomerular endothelium, slit membranes, and epithelium after in vivo injection. Localization of antigens and bound IgGs by immunoelectron microscopy. Am J Pathol (1990) 1.04
Atrophic gastritis in Sjögren's syndrome. Morphologic, biochemical, and immunologic findings. Arthritis Rheum (1985) 1.03
Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy. Gut (2000) 1.02
A cell-type specific ganglioside of glomerular podocytes in rat kidney: an O-acetylated GD3. Kidney Int (1992) 1.02
Topical lomefloxacin twice daily compared with fucidic acid in acute bacterial conjunctivitis. Acta Ophthalmol Scand (1996) 1.01
Nephritogenic and non-nephritogenic epithelial antigens in autoimmune and passive Heymann nephritis. Lab Invest (1984) 1.00
Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure. J Clin Endocrinol Metab (1987) 1.00
Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes. Diabetes (1988) 1.00
Enzyme-immunoassay in the detection of hepatitis B surface antigen. J Immunol Methods (1977) 1.00
Urinary transforming growth factor-beta 1 in membranous glomerulonephritis. Nephrol Dial Transplant (1997) 0.99
Affinity of IgM and IgG antibodies. Immunochemistry (1970) 0.98
Feasibility of commercial interferon-gamma-based methods for the diagnosis of latent Mycobacterium tuberculosis infection in Finland, a country of low incidence and high bacille Calmette-Guérin vaccination coverage. Clin Microbiol Infect (2007) 0.98
Fibronectin as a marker for the glomerular mesangium in immunohistology of kidney biopsies. Lab Invest (1980) 0.98
Familial and sporadic inflammatory bowel disease: comparison of clinical features and serological markers in a genetically homogeneous population. Scand J Gastroenterol (2002) 0.98
Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures. Epilepsy Res (2000) 0.97
The O75X adhesin of uropathogenic Escherichia coli: receptor-active domains in the canine urinary tract and in-vitro interaction with laminin. Microb Pathog (1987) 0.97
Mannan binding lectin deficiency and concomitant immunodefects. Arch Dis Child (1998) 0.96
A peptide derived from the intercellular adhesion molecule-2 regulates the avidity of the leukocyte integrins CD11b/CD18 and CD11c/CD18. J Cell Biol (1995) 0.96
Seroepidemiological study of Helicobacter pylori infection in infancy. Arch Dis Child Fetal Neonatal Ed (1996) 0.96
Organogenesis in a defined medium supplemented with transferrin. Cell Differ (1981) 0.96
Intestinal inflammation in children with atopic eczema: faecal eosinophil cationic protein and tumour necrosis factor-alpha as non-invasive indicators of food allergy. Clin Exp Allergy (1996) 0.95
Cytoskeleton antibodies in chronic active hepatitis, primary biliary cirrhosis, and alcoholic liver disease. Hepatology (1983) 0.94
Bacterial contamination and closed suction drainage in open meniscectomy of the knee. Ann Chir Gynaecol (1993) 0.94
A prospective study of 63 couples with a history of recurrent spontaneous abortion: contributing factors and outcome of subsequent pregnancies. Hum Reprod (1993) 0.94
Nephron segment and cell-type specific expression of gangliosides in the developing and adult kidney. Kidney Int (1994) 0.94
Rat glomerular cells do not express podocytic markers when cultured in vitro. Lab Invest (1991) 0.94
Resolution of renal amyloidosis secondary to rheumatoid arthritis. Acta Med Scand (1979) 0.93
Upper gastrointestinal endoscopy in recurrent abdominal pain of childhood. J Pediatr Gastroenterol Nutr (1993) 0.93
Membrane antigens shared by renal proximal tubules and other epithelia associated with absorption and excretion. Clin Exp Immunol (1976) 0.93
Adjuvant effect of bacterial LPS and/or alum precipitation in responses to polysaccharide and protein antigens. Immunology (1984) 0.92
Decrease of glomerular disialogangliosides in puromycin nephrosis of the rat. Am J Pathol (1996) 0.92
Induction of brush border antigens of the proximal tubule in the developing kidney. Dev Biol (1980) 0.92
Nephrin in human lymphoid tissues. Cell Mol Life Sci (2006) 0.91
Polymorphism and deficiency of human factor H-related proteins p39 and p37. Immunogenetics (1992) 0.91
New immunochromatographic rapid test for diagnosis of acute Puumala virus infection. J Clin Microbiol (2001) 0.91
Maternal antibodies partly inhibit an active antibody response to routine tetanus toxoid immunization in infants. J Infect Dis (1992) 0.91